Last reviewed · How we verify

NCT05522179

Nutritional Supplements and Foot Surgery

Completed NA Last updated 1 August 2023
What this trial tests

NA trial testing NutraHeal in Foot Injuries and Disorders in 46 participants. Completed in 30 July 2023.

Timeline
29 August 2022
Primary endpoint
17 March 2023
30 July 2023

Quick facts

Lead sponsorNutraHeal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment46
Start date29 August 2022
Primary completion17 March 2023
Estimated completion30 July 2023
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

NutraHeal

Who can join

Adults 20 to 80, any sex, with Foot Injuries and Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized trial wherein participants will be assigned to NutraHeal™, NutraHeal Plus™, or standard of care for 1 week prior to foot surgery and 3 weeks after surgery. The central hypothesis is that among patients undergoing surgery, nutritional supplements that maintain energy production, muscle structure, immune function, and response to pain will support recovery from surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05522179.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing